Quick Answer
BIOCRYST PHARMACEUTICALS INC reported Shares Outstanding of 213.06 million shares for fiscal year 2025.
BIOCRYST PHARMACEUTICALS INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 213.06M | +2.2% |
| 2024 | 208.54M | +1.3% |
| 2023 | 205.77M | +9.5% |
| 2022 | 187.91M | +1.9% |
| 2021 | 184.35M | +4.2% |
| 2020 | 176.88M | +14.8% |
| 2019 | 154.08M | +40.0% |
| 2018 | 110.06M | +11.8% |
| 2017 | 98.41M | +33.4% |
| 2016 | 73.78M | +0.6% |
| 2015 | 73.36M | +1.9% |
| 2014 | 71.95M | +21.8% |
| 2013 | 59.09M | +16.1% |
| 2012 | 50.89M | +11.5% |
| 2011 | 45.66M | +1.6% |
| 2010 | 44.96M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 210.52M | +1.6% | +0.3% |
| June 30, 2025 | 209.91M | +1.6% | +0.3% |
| March 31, 2025 | 209.21M | +1.4% | +0.3% |
| December 31, 2024 | 208.54M | +1.3% | +0.7% |
| September 30, 2024 | 207.12M | +9.1% | +0.2% |
| June 30, 2024 | 206.63M | +9.0% | +0.1% |
| March 31, 2024 | 206.35M | +9.2% | +0.3% |
| December 31, 2023 | 205.77M | +9.5% | +8.4% |
- BIOCRYST PHARMACEUTICALS INC showed an increase of +2.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, BIOCRYST PHARMACEUTICALS INC’s shares outstanding has grown by 373.9% (from 44.96 million shares to 213.06 million shares).
- The most recent figure is from BIOCRYST PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: